Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says
Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says zbecker Tue, 04/02/2024 - 16:45
Eli Lilly's popular diabetes drug Mounjaro to face continued supply squeeze through April, FDA says zbecker Tue, 04/02/2024 - 16:45
KBI Biopharma taps pharma veteran to oversee quality and regulatory affairs esagonowsky Tue, 04/02/2024 - 13:08
With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO kdunleavy Tue, 04/02/2024 - 12:40
What does the future of specialist distribution look like? jpiatt Tue, 04/02/2024 - 12:10
Teva, Viatris revive patent challenge on J&J's long-acting schizophrenia blockbuster Invega Sustenna fkansteiner Tue, 04/02/2024 - 10:57
Acorda inks $185M asset sale with Merz, files for bankruptcy after years of disappointing sales zbecker Tue, 04/02/2024 - 10:54
Lonza poaches CEO from rival as it prepares to reap rewards of Roche plant buy aliu Tue, 04/02/2024 - 10:26
Courts clear hurdles for Liquidia's Yutrepia, potentially allowing for new rival to United's PAH franchise kdunleavy Tue, 04/02/2024 - 08:33
Aurobindo's Eugia recalls one lot of muscle relaxant because of possible contamination jkeenan Tue, 04/02/2024 - 08:07